ResearchPeptide
NAD+
Published Research
PubMed-indexed studies for NAD+
Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD(+) synthesis via enterohepatic circulation.
View on PubMed →NAD(+) Intermediates: The Biology and Therapeutic Potential of NMN and NR.
View on PubMed →Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction.
View on PubMed →Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults.
View on PubMed →Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD(+) Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures.
View on PubMed →A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
View on PubMed →Research-Grade NAD+
⚠️ For laboratory research only. Not for human use.